Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib

Front Mol Biosci. 2021 Aug 30:8:727969. doi: 10.3389/fmolb.2021.727969. eCollection 2021.

Lei Zhang¹, Zhi-Ping Yan^{2

3

4}, Zhong-Heng Hou¹, Peng Huang¹, Min-Jie Yang^{2

3

4}, Shuai Zhang¹, Shen Zhang¹, Shao-Hua Zhang⁵, Xiao-Li Zhu¹, Cai-Fang Ni¹, Qiang Li⁶

¹ Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China.
² Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
³ Shanghai Institution of Medical Imaging, Shanghai, China.
⁴ National Clinical Research Center for Interventional Medicine, Shanghai, China.
⁵ Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen, China.
⁶ Department of Radiology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.

Abstract

[This corrects the article DOI: 10.3389/fmolb.2021.624366.].

Keywords: HCC; TACE; lymphocytes; neutrophils; platelet count; sorafenib.